Skip to main content
Mallory
MediumVulnerability

CVE-2026-105813: Cleartext Session Token Storage in Ivanti UWM Neurons Hybrid

Published Nov 10, 2026 · Updated 1 day ago
Trending this weekNot trendingOutside this week’s top 100
Mention activity · 30 daysNo mention activity in the last 30 days.
CVSS6.3Medium · v3.1
EPSS0.12%2nd percentile
CISA KEVNoNot listed
In the wildNoneNo exploitation reported
IdentifiersCVE-2026-105813CWE-312 · Cleartext Storage of Sensitive…

CVE-2026-105813 is a cleartext storage vulnerability in Ivanti User Workspace Manager (UWM) Neurons Hybrid deployments before version 2026.4. A local authenticated attacker with low privileges can retrieve another local user's session token, potentially enabling unauthorized access in that user's session context. The vulnerability is rated medium severity with a CVSS score of 6.3. UWM on-premise deployments and Ivanti Neurons for App Control are not affected.

Do you run this?See affected versions in your environment and whether adversaries are exploiting this vulnerability against assets like yours.
Check your exposure
Analyst brief

Impact, mitigation & remediation

What it means and what to do now: patch path, interim mitigations, and the assume-compromise checklist.

Impact

What an attacker gets, and what they’ve been doing with it.

Successful exploitation exposes another local user's session token and may enable session impersonation or unauthorized access under that user's identity. The vulnerability is rated as having low confidentiality, integrity, and availability impacts, with changed scope.

Mitigation

If you can’t patch tonight, do this now.

No vendor-specified temporary mitigation or workaround is available. As an interim precaution, restrict local access to affected systems to trusted users; this does not replace installing the security update.

Remediation

Patch, then assume compromise.

Update affected Ivanti UWM Neurons Hybrid deployments to version 2026.4 or later. The fixed release is available through the Ivanti License System (ILS). Verify the installed version after updating.

Public exploits

Exploits

No public exploits tracked yet. Mallory keeps watching.

View more in app →
No public exploit code observed for this vulnerability. Mallory keeps watching.
FAQ

Frequently asked questions

Is CVE-2026-105813 exploited in the wild?
As of Nov 16, 2026, Mallory has no reports of CVE-2026-105813 being exploited in the wild. It is not listed in CISA KEV.
Is there a public exploit for CVE-2026-105813?
As of Nov 16, 2026, Mallory has found no public exploit for CVE-2026-105813.
Is there a patch for CVE-2026-105813?
Update affected Ivanti UWM Neurons Hybrid deployments to version 2026.4 or later. The fixed release is available through the Ivanti License System (ILS).
How severe is CVE-2026-105813?
CVE-2026-105813 has a CVSS v3.1 score of 6.3 (Medium) and an EPSS score of 0.12% (2nd percentile) as of Nov 16, 2026.
Activity feed

Recent activity

6 sources tracked across advisories and community write-ups. News coverage will land here when it surfaces.

View more in app →

No news coverage yet. Advisories and community discussion only.

Do you run this?See affected versions in your environment and whether adversaries are exploiting this vulnerability against assets like yours.
Check your exposure
Mallory platform

The version that knows your environment.

This page is what’s public. Mallory adds the parts that aren’t: which of your assets are affected, which adversaries are exploiting it right now, and which detections to deploy tonight.
Exposure mappingQuery your assets running an affected version, and investigate the blast radius.
Threat actor evidenceEvery report linking this CVE to a named adversary.
Associated malwareMalware families linked to this CVE, with evidence and IOCs.
Detection signaturesYARA, Sigma, Snort, and vendor rules, auto-deployed to your SIEM.
Vendor-by-vendor mappingCross-references every affected SKU, including bundled OEM variants.
Social activityCommunity discussion across Reddit, Mastodon, and other social sources.